The clinical research industry has spent significant time defining diversity, equity, and inclusion (DE&I) and discussing present needs for clinical trials. However, why do we truly need to focus on DE&I? What is the science behind why DE&I matters for the future of our medicines? This panel will discuss the scientific evidence driving the emphasis on diversity in clinical trials.

Location: Mercer Date: April 8, 2024 Time: 9:15 - 9:45 Quita Highsmith